InvestorsHub Logo
Followers 97
Posts 10951
Boards Moderated 1
Alias Born 06/05/2006

Re: StockLogistics post# 29

Saturday, 10/29/2022 11:17:05 AM

Saturday, October 29, 2022 11:17:05 AM

Post# of 40
$EMMA - Seems like this one has a ton of potential. CEO has been buying shares every week it seems like. Insiders and 5%+ holders own over 78% of the company. Even at .47 it’s market cap is low for its potential. The company is working on getting FDA approval to use Endari to treat Diverticulosis. That is a potential $8-20 Billion market in the US and a $35 billion market in the EU.
I can see why they now want to up list to the Nasdaq! The market cap is only like $23 million at .47
Also once Endari gets approved in Africa and South America, revenues will skyrocket. Company expects approval by the end of the year. It should get approved since it’s already FDA approved in the US and approved in Europe as well.
It’s no wonder why the CEO has been buying so many shares. He has bought a lot well above $1 too. The CEO even provides loans to the company when cash runs low instead of diluting the stock.
I think this is one pharma stock that will end up turning the average person into a multimillionaire IMO. The possibilities are insane.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EMMA News